Seminars in Nuclear Medicine
Volume 31, Issue 3 , Pages 177-190, July 2001

The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment

  • Rachel Bar-Shalom

      Affiliations

    • Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    • Division of Nuclear Medicine, Department of Radiology, The New York Presbyterian Hospital, Weill-Medical College of Cornell University, New York, NY, USA
    • Corresponding Author InformationAddress reprint requests to Rachel Bar-Shalom, MD, Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel.
  • ,
  • Maya Mor

      Affiliations

    • Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    • Division of Nuclear Medicine, Department of Radiology, The New York Presbyterian Hospital, Weill-Medical College of Cornell University, New York, NY, USA
  • ,
  • Nikolai Yefremov

      Affiliations

    • Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    • Division of Nuclear Medicine, Department of Radiology, The New York Presbyterian Hospital, Weill-Medical College of Cornell University, New York, NY, USA
  • ,
  • Stanley J. Goldsmith

      Affiliations

    • Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    • Division of Nuclear Medicine, Department of Radiology, The New York Presbyterian Hospital, Weill-Medical College of Cornell University, New York, NY, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0001-2998(01)80018-0

doi:10.1053/snuc.2001.23519

Seminars in Nuclear Medicine
Volume 31, Issue 3 , Pages 177-190, July 2001